Luba Greenwood, JD
Luba Greenwood is a distinguished executive, investor, and company builder with over 20 years of experience in the healthcare and tech sectors. She has served as CEO of multiple biotechnology companies, including currently serving as CEO of Gallop Oncology and most recently as CEO and Board Chair of Kojin Tx. She has founded and served as Managing Partner of the Dana Farber Cancer Institute venture fund, Binney Street Capital. She is also entrepreneur-in residence at Puretech where she plays a key role in PureTech’s oncology programs.
Ms. Greenwood has previously served in leadership roles at Google (Verily) and Roche. Luba has led $15B+ in deals and investments across multiple therapeutic areas, diagnostics, life sciences and tech sectors globally. She is a Thought Leader for
the New England Journal of Medicine Catalyst and serves on the Investor Committee for the National Cancer Institute.
​
Ms. Greenwood has extensive board experience globally and serves on public and private boards, across multiple industries, including In8Bio (INAB), BenchSci, Stalicla, Abcam (ABCAM), Traws Pharma (TRAW), Closed Loop Medicine, and Massachusetts Biotechnology Council (MassBio). Ms. Greenwood began her career practicing law at WilmerHale and is an expert in regulatory, securities, and intellectual property matters. She also served as a lecturer at Harvard University in the School of Engineering and Applied Sciences.
About the Sisterhood
The Biotech CEO Sisterhood is a vibrant community dedicated to championing the success of women leaders in the biopharma industry. Rooted in a culture of mutual support and authenticity, the Sisterhood aims to inspire and uplift women while driving meaningful conversations and impact across the industry. As part of our commitment to nurturing the current and future generations of biotech leaders, the Sisterhood hosts summits, local events, and educational sessions. These programs encourage dialogue about the challenges facing women in biotech, share best practices, and enhance leadership effectiveness. Since its inception in 2022, the Biotech CEO Sisterhood has grown to 300+ members. To follow our progress and learn more, please follow us on LinkedIn.
Follow BiotechTV
Also look for unique social pages for BiotechTV U.
.png){kind=logo}
Sponsor Spotlight
Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.